	現金と同等		日付
Acadia Pharmaceuticals	USD 819.69M	27.33M	2025-12
Adma Biologics	USD 87.63M	26.24M	2025-12
ALKERMES	USD 351.55M	37.02M	2026-03
Alterity Therapeutics Limited	AUD 15.77M	9.56M	2023-06
AstraZeneca	USD 7.56B	1.85B	2026-03
BioCryst Pharmaceuticals	USD 335.91M	251.83M	2025-12
Bristol-Myers Squibb	USD 9.57B	635M	2026-03
Cipla	INR 7.96B	39.9M	2025-09
Clal Biotechnology	ILS 5.73M	1.71M	2023-12
Compugen	USD 90.6M	83.14M	2025-12
CSL	USD 2.16B	633M	2025-06
Eli Lilly	USD 5.28B	1.99B	2026-03
Esperion Therapeutics	USD 92.45M	6.39M	2025-09
GlaxoSmithKline	GBP 3.44B	292M	2026-03
Grifols	EUR 979.78M	334.84M	2024-12
Halozyme Therapeutics	USD 133.82M	285.84M	2025-12
Ionis Pharmaceuticals	USD 1.92B	758M	2026-03
J&J	USD 21.69B	1.98B	2026-03
Merck	USD 5.33B	9.24B	2026-03
Minerva Neurosciences	USD 82.3M	70.02M	2025-12
Neurocrine Biosciences	USD 266.5M	446.5M	2026-03
Novartis	USD 6.88B	4.56B	2026-03
Novavax	USD 240.63M	27.39M	2025-12
Pfizer	USD 1.7B	561M	2026-03
Roche Holding	CHF 7.55B	579M	2025-06
Sanofi	EUR 7.66B	1.25B	2025-12
Takeda	JPY 654.94B	26.55B	2025-12
Vanda Pharmaceuticals	USD 84.85M	14.83M	2025-12